Kinopharma, Inc.
Records under this name other than the patents Kinopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 3 of 3 · Back to Kinopharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,765,941 | Aniline Derivative Having Anti-RNA Viral Activity Lapsed on the fee record Ended Jul 1, 2026 · High confidence | Lapsed on the fee record | Ended Jul 1, 2026 | High confidence |
| US 7,928,283 | Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in nematodes Lapsed on the fee record Ended Apr 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2023 | From the USPTO record |
| US 7,786,151 | Therapeutic composition of treating abnormal splicing caused by the excessive kinase induction Formerly held Lapsed on the fee record Ended Aug 31, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 31, 2022 | From the USPTO record |